Original language | English (US) |
---|---|
Pages (from-to) | 305-307 |
Number of pages | 3 |
Journal | American Journal of Kidney Diseases |
Volume | 79 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2022 |
Externally published | Yes |
ASJC Scopus subject areas
- Nephrology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: American Journal of Kidney Diseases, Vol. 79, No. 2, 02.2022, p. 305-307.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Association of Kidney Function With 30-Day Mortality Following SARS-CoV-2 Infection in Nursing Home Residents
T2 - A Retrospective Cohort Study
AU - Thorsness, Rebecca
AU - Raines, Nathan H.
AU - White, Elizabeth M.
AU - Santostefano, Christopher M.
AU - Parikh, Samir M.
AU - Riester, Melissa R.
AU - Feifer, Richard A.
AU - Mor, Vincent
AU - Zullo, Andrew R.
N1 - Funding Information: This research was supported by the National Institute on Aging (NIA) ( 3P01AG027296-11S1 ; Principal Investigator: VM). NHR is supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant T32 DK007199 (Pollak) and the Doris Duke Physician Scientist Fellowship grant 63408. SMP is supported by grants R35HL139424, R01DK095072, and R01AG027002 from the National Heart Lung Blood Institute, NIDDK, and NIA. ARZ is supported by NIA grants R01AG045441, RF1AG061221, R01AG065722, and R21AG061632. Funders played no role in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication. Funding Information: Resarch idea and study design: all authors; data acquisition: VM, RAF; statistical analysis: RT, CMS; interpretation: all authors; supervision/mentorship: ARZ, SMP, VM. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for the individual's own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate. This research was supported by the National Institute on Aging (NIA) (3P01AG027296-11S1; Principal Investigator: VM). NHR is supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant T32 DK007199 (Pollak) and the Doris Duke Physician Scientist Fellowship grant 63408. SMP is supported by grants R35HL139424, R01DK095072, and R01AG027002 from the National Heart Lung Blood Institute, NIDDK, and NIA. ARZ is supported by NIA grants R01AG045441, RF1AG061221, R01AG065722, and R21AG061632. Funders played no role in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication. SMP is a consultant for Janssen and Mission Therapeutics; member of scientific advisory boards for Cytokinetics and Aerpio; and recipient of royalties from UpToDate and honoraria from the American Society of Nephrology. ARZ is supported by grant funding paid directly to Brown University by Sanofi Pasteur for collaborative research on infections and vaccinations in nursing home residents as well as respiratory syncytial virus in infants. VM serves as Chair of the Scientific Advisory Committee at NaviHealth, Inc, was former Chair of the Independent Quality Committee at HCR ManorCare, and is the former Director of PointRight Inc, where he holds less than 1% equity; and received personal fees from NaviHealth outside the submitted work. The remaining authors declare that they have no relevant financial interests. We thank Jeff Hiris, Yoojin Lee, and Cyrus Kosar from Brown University and the Genesis HealthCare IT leadership team for their ongoing technical support and guidance on this project. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US Government. Received June 8, 2021. Evaluated by 2 external peer reviewers, with direct editorial input from a Statistics/Methods Editor, an Associate Editor, and the Editor-in-Chief. Accepted in revised form September 12, 2021.
PY - 2022/2
Y1 - 2022/2
UR - http://www.scopus.com/inward/record.url?scp=85122687707&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122687707&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2021.09.009
DO - 10.1053/j.ajkd.2021.09.009
M3 - Letter
C2 - 34656641
AN - SCOPUS:85122687707
SN - 0272-6386
VL - 79
SP - 305
EP - 307
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 2
ER -